Therapeutic non-ectasia applications of cornea cross-linking

References

• Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Clinical trial. Am J Ophthalmol 2003; 135: 620–627. doi:10.1016/S0002-9394(02)02220-1.
   PubMed Web of Science ®Google Scholar
• Ziaei M, Barsam A, Shamie N et al. Reshaping procedures for the surgical management of corneal ectasia. J Cataract Refract Surg 2015 Apr; 41: 842–872. doi:10.1016/j.jcrs.2015.03.010.
   PubMed Web of Science ®Google Scholar
• Wollensak G, Redl B. Gel electrophoretic analysis of corneal collagen after photodynamic cross-linking treatment. Cornea 2008 Apr; 27: 353–356. doi:10.1097/ICO.0b013e31815cf66a.
   PubMed Web of Science ®Google Scholar
• Bottós KM, Dreyfuss JL, Regatieri CV et al. Immunofluorescence confocal microscopy of porcine corneas following collagen cross-linking treatment with riboflavin and ultraviolet a. J Refract Surg 2008 Sep; 24: S715–9. doi:10.3928/1081597x-20080901-14.
   PubMed Web of Science ®Google Scholar
• Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res 2004 Jul; 29: 35–40. doi:10.1080/02713680490513182.
   PubMed Web of Science ®Google Scholar
• Khor W-B, Prajna VN, Garg P et al. The Asia cornea society infectious keratitis study: a prospective multicenter study of infectious keratitis in Asia. Am J Ophthalmol 2018; 195: 161–170. doi:10.1016/j.ajo.2018.07.040.
   PubMed Web of Science ®Google Scholar
• Keay L, Edwards K, Naduvilath T et al. Microbial keratitis: predisposing factors and morbidity. Ophthalmology 2006; 113: 109–116. doi:10.1016/j.ophtha.2005.08.013.
   PubMed Web of Science ®Google Scholar
• Pascolini D, Mariotti SP. Global estimates of visual impairment. Br J Ophthalmol 2012; 96: 614–618. doi:10.1136/bjophthalmol-2011-300539.
   PubMed Web of Science ®Google Scholar
• Sony P, Sharma N, Vajpayee RB et al. Therapeutic keratoplasty for infectious keratitis: a review of the literature. Eye Cont Lens 2002; 28: 111–118.
   Google Scholar
• Henry CR, Flynn JH, Miller D et al. Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes. 2012; 119: 2443–2449. doi:10.1016/j.ophtha.2012.06.030.
   Google Scholar
• Ung L, Bispo PJ, Shanbhag SS et al. The persistent dilemma of microbial keratitis: global burden, diagnosis, and antimicrobial resistance. Surv Ophthalmol 2019; 64: 255–271. doi:10.1016/j.survophthal.2018.12.003.
   PubMed Web of Science ®Google Scholar
• Schnitzler E, Spörl E, Seiler T. Bestrahlung der Hornhaut mit UV-Licht und Riboflavingabe als neuer Behandlungsversuch bei einschmelzenden Hornhautprozessen, erste Ergebnisse bei vier Patienten. Crosslinking of the corneal collagen by UV-radiation with Riboflavin for the mode of treatment melting ulcera of the cornea, first results of four patients. Klin Monbl Augenheilkd 2000 Dec 31; 217: 190–193. doi:10.1055/s-2000-10344.
   PubMedGoogle Scholar
• Naseem I, Ahmad M, Hadi SM. Effect of alkylated and intercalated DNA on the generation of superoxide anion by riboflavin. Biosci Rep 1988; 8: 485–492. doi:10.1007/BF01121647.
   PubMed Web of Science ®Google Scholar
• Tsugita A, Okada Y, Uehara K. Photosensitized inactivation of ribonucleic acids in the presence of riboflavin. Biochimica Et Biophysica Acta (BBA) - Nucleic Acids Protein Synthesis 1965; 103: 360–363. doi:10.1016/0005-2787(65)90182-6.
   PubMed Web of Science ®Google Scholar
• Müller L, Thiel M, Kipfer-Kauer A et al. Corneal cross-linking as supplementary treatment option in melting keratitis: a case series. Klinische Monatsblätter für Augenheilkunde 2012; 229: 411–415. doi:10.1055/s-0031-1299420.
   PubMed Web of Science ®Google Scholar
• Iseli HP, Thiel MA, Hafezi F et al. Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea 2008; 27: 590–594. doi:10.1097/ICO.0b013e318169d698.
   PubMed Web of Science ®Google Scholar
• Dean SJ, Petty A, Swift S et al. Efficacy and safety assessment of a novel ultraviolet C device for treating corneal bacterial infections. Clin Experiment Ophthalmol 2011; 39: 156–163. doi:10.1111/j.1442-9071.2010.02471.x.
   PubMed Web of Science ®Google Scholar
• Hafezi F, Hosny M, Shetty R et al. PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial. Eye Vision 2022 Jan 7; 9: 2. doi:10.1186/s40662-021-00272-0.
   Web of Science ®Google Scholar
• Shetty R, Nagaraja H, Jayadev C et al. Collagen crosslinking in the management of advanced non-resolving microbial keratitis. 2014; 98: 1033–1035. doi:10.1136/bjophthalmol-2014-304944.
   Google Scholar
• Agrawal N, Singh SK. Collagen cross-linking in recalcitrant corneal ulcers: a case series. 2016; 8: 47–53. doi:10.3126/nepjoph.v8i1.16156.
   Google Scholar
• Price MO, Tenkman LR, Schrier A et al. Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology. 2012; 28: 706–713. doi:10.3928/1081597X-20120921-06.
   Google Scholar
• Skaat A, Zadok D, Goldich Y et al. Riboflavin/UVA photochemical therapy for severe infectious keratitis. Eur J Ophthalmol 2014; 24: 21–28. doi:10.5301/ejo.5000330.
   PubMed Web of Science ®Google Scholar
• Sorkhabi R, Sedgipoor M, Mahdavifard A. Collagen cross-linking for resistant corneal ulcer. 2013; 33: 61–66. doi:10.1007/s10792-012-9633-2.
   Google Scholar
• Zloto O, Barequet IS, Weissman A et al. Does PACK-CXL change the prognosis of resistant infectious keratitis? 2018; 34: 559–563. doi:10.3928/1081597X-20180705-01.
   Google Scholar
• Anwar HM, El-Danasoury E-D, Hashem H. Corneal collagen crosslinking in the treatment of infectious keratitis. Clin Ophthalmol 2011; 5: 1277. doi:10.2147/OPTH.S24532.
   PubMedGoogle Scholar
• Li M, Yu T, Gao X et al. Accelerated corneal collagen cross-linking in clinical management of infectious keratitis. J Int Med Res 2020; 48: 0300060520926411. doi:10.1177/0300060520926411.
   PubMed Web of Science ®Google Scholar
• Makdoumi K, Mortensen J, Sorkhabi O et al. UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefes Arch Clin Exp Ophthalmol 2012; 250: 95–102. doi:10.1007/s00417-011-1754-1.
   PubMed Web of Science ®Google Scholar
• Panda A, Krishna SN, Kumar SJC. Photo-activated riboflavin therapy of refractory corneal ulcers. Cornea 2012; 31: 1210–1213. doi:10.1097/ICO.0b013e31823f8f48.
   PubMed Web of Science ®Google Scholar
• Kasetsuwan N, Reinprayoon U, Satitpitakul V. Photoactivated chromophore for moderate to severe infectious keratitis as an adjunct therapy: a randomized controlled trial. Am J Ophthalmol 2016; 165: 94–99. doi:10.1016/j.ajo.2016.02.030.
   PubMed Web of Science ®Google Scholar
• Said DG, Elalfy MS, Gatzioufas Z et al. Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting. Ophthalmology 2014; 121: 1377–1382. doi:10.1016/j.ophtha.2014.01.011.
   PubMed Web of Science ®Google Scholar
• Gulias-Cañizo R, Benatti A, De Wit-Carter G et al. Photoactivated chromophore for keratitis-corneal collagen cross-linking (PACK-CXL) improves outcomes of treatment-resistant infectious keratitis. 2020; 14: 4451. doi:10.2147/OPTH.S284306.
   Google Scholar
• Ozbek-Uzman S, Yalniz-Akkaya Z, Burcu A. Corneal collagen cross-linking with photoactivated chromophore for infectious keratitis after penetrating keratoplasty. Cornea 2020; 39: 283–289. doi:10.1097/ICO.0000000000002210.
   PubMed Web of Science ®Google Scholar
• Bamdad S, Khalili MR, Khosravi A et al. Corneal cross-linking as an adjunct for the management of refractory fungal keratitis. Middle East Afr J Ophthalmol 2020; 27: 204. doi:10.4103/meajo.MEAJO_130_19.
   PubMed Web of Science ®Google Scholar
• Uddaraju M, Mascarenhas J, Das MR et al. Corneal cross-linking as an adjuvant therapy in the management of recalcitrant deep stromal fungal keratitis: a randomized trial. Am J Ophthalmol 2015; 160: 131–134. e5. doi:10.1016/j.ajo.2015.03.024.
   PubMed Web of Science ®Google Scholar
• Wei A, Wang K, Wang Y et al. Evaluation of corneal cross-linking as adjuvant therapy for the management of fungal keratitis. Graefes Arch Clin Exp Ophthalmol 2019; 257: 1443–1452. doi:10.1007/s00417-019-04314-1.
   PubMed Web of Science ®Google Scholar
• Prajna NV, Radhakrishnan N, Lalitha P et al. Cross-linking–assisted infection reduction: a randomized clinical trial evaluating the effect of adjuvant cross-linking on outcomes in fungal keratitis. Ophthalmology 2020; 127: 159–166. doi:10.1016/j.ophtha.2019.08.029.
   PubMed Web of Science ®Google Scholar
• Basaiawmoit P, Selvin SST, Korah S. PACK-CXL in reducing the time to heal in suppurative corneal ulcers: observations of a pilot study from South India. Cornea 2018; 37: 1376–1380. doi:10.1097/ICO.0000000000001667.
   PubMed Web of Science ®Google Scholar
• Ting DSJ, Henein C, Said DG et al. Photoactivated chromophore for infectious keratitis–corneal cross-linking (PACK-CXL): a systematic review and meta-analysis. Ocul Surf 2019; 17: 624–634. doi:10.1016/j.jtos.2019.08.006.
   PubMed Web of Science ®Google Scholar
• Khalili MR, Jahadi HR, Karimi M et al. Corneal collagen cross-linking for treatment of bacterial and herpetic keratitis. J Clin Diagn Res 2017; 11: NC12. doi:10.7860/JCDR/2017/24863.10253.
   PubMed Web of Science ®Google Scholar
• Knyazer B, Krakauer Y, Tailakh MA et al. Accelerated corneal cross-linking as an adjunct therapy in the management of presumed bacterial keratitis: a cohort study. J Refract Surg 2020; 36: 258–264. doi:10.3928/1081597X-20200226-02.
   PubMed Web of Science ®Google Scholar
• Davis SA, Bovelle R, Han G et al. Corneal collagen cross‐linking for bacterial infectious keratitis. Cochrane Database Syst Rev 2020; doi:10.1002/14651858.CD013001.pub2.
   Web of Science ®Google Scholar
• Erdem E, Harbiyeli II, Boral H et al. Corneal collagen cross-linking for the management of mycotic keratitis. Mycopathologia 2018; 183: 521–527. doi:10.1007/s11046-018-0247-8.
   PubMed Web of Science ®Google Scholar
• Abbouda A, Estrada AV, Rodriguez AE et al. Anterior segment optical coherence tomography in evaluation of severe fungal keratitis infections treated by corneal crosslinking. Eur J Ophthalmol 2014; 24: 320–324. doi:10.5301/ejo.5000424.
   PubMed Web of Science ®Google Scholar
• Jeyalatha Mani V, Parthasarathy D, Padmanabhan P et al. Therapeutic effect of corneal crosslinking on fungal keratitis: efficacy of corneal collagen crosslinking as an adjuvant therapy for fungal keratitis in a tertiary eye hospital in south India. Ocul Immunol Inflamm 2020; 29: 1–8. doi:10.1080/09273948.2020.1770296.
   Web of Science ®Google Scholar
• Vajpayee RB, Shafi SN, Maharana PK et al. Evaluation of corneal collagen cross‐linking as an additional therapy in mycotic keratitis. Clin Experiment Ophthalmol 2015; 43: 103–107. doi:10.1111/ceo.12399.
   PubMed Web of Science ®Google Scholar
• Khan YA, Kashiwabuchi RT, Martins SA et al. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology 2011; 118: 324–331. doi:10.1016/j.ophtha.2010.06.041.
   PubMed Web of Science ®Google Scholar
• Cristian C, Marco C, Arturo K et al. Accelerated collagen cross-linking in the management of advanced Acanthamoeba keratitis. Arq Bras Oftalmol 2019; 82: 103–106. doi:10.5935/0004-2749.20190018.
   PubMed Web of Science ®Google Scholar
• Nateghi Pettersson M, Lagali N, Mortensen J et al. High fluence PACK-CXL as adjuvant treatment for advanced Acanthamoeba keratitis. Am J Ophthalmol Case Rep 2019; 15: 100499. doi:10.1016/j.ajoc.2019.100499.
   PubMedGoogle Scholar
• Watson SH, Shekhawat NS, Daoud YJ. Treatment of recalcitrant Acanthamoeba keratitis with photoactivated chromophore for infectious keratitis corneal collagen cross-linking (PACK-CXL). Am J Ophthalmol Case Rep 2022 Mar 1; 25: 101330. doi:10.1016/j.ajoc.2022.101330.
   PubMedGoogle Scholar
• Abbouda A, Alió JL. PACK-CXL treatment of acanthamoeba keratitis following PRK. In: Alió JL, Azar DT, Abbouda A, Aswad AE, editors. Difficult and complicated cases in refractive surgery. Berlin, Heidelberg: Springer; 2015. p. 411–413.
   Google Scholar
• Atalay HT, Dogruman-Al F, Sarzhanov F et al. Effect of riboflavin/rose bengal-mediated PACK-CXL on acanthamoeba trophozoites and cysts in vitro. Curr Eye Res 2018; 43: 1322–1325. doi:10.1080/02713683.2018.1501074.
   PubMed Web of Science ®Google Scholar
• Ferrari G, Iuliano L, Viganò M et al. Impending corneal perforation after collagen cross-linking for herpetic keratitis. 2013; 39: 638–641. doi:10.1016/j.jcrs.2013.02.006.
   Google Scholar
• Kymionis GD, Portaliou DM. Corneal collagen crosslinking and herpetic keratitis. J Cataract Refract Surg 2013; 39: 1281. doi:10.1016/j.jcrs.2013.06.002.
   PubMed Web of Science ®Google Scholar
• Roy AS, Dupps WJ. Patient-specific computational modeling of keratoconus progression and differential responses to collagen cross-linking. Investig Ophthalmol Vis Sci 2011; 52: 9174–9187. doi:10.1167/iovs.11-7395.
   PubMed Web of Science ®Google Scholar
• Sachdev GS, Ramamurthy S, Dandapani R. Photorefractive intrastromal corneal crosslinking for treatment of low myopia: clinical outcomes using the transepithelial approach with supplemental oxygen. J Cataract Refract Surg 2020 Mar; 46: 428–433. doi:10.1097/j.jcrs.0000000000000073.
   PubMed Web of Science ®Google Scholar
• Kanellopoulos J. Novel myopic refractive correction with transepithelial very high-fluence collagen cross-linking applied in a customized pattern: early clinical results of a feasibility study. Clin Ophthalmol 2014 Apr 1; 697. doi:10.2147/opth.s59934.
   PubMedGoogle Scholar
• Kanellopoulos AJ, Dupps WJ, Seven I et al. Toric topographically customized transepithelial, pulsed, very high-fluence, higher energy and higher riboflavin concentration collagen cross-linking in keratoconus. Case Rep Ophthalmol 2014 May; 5: 172–180. doi:10.1159/000363371.
   PubMedGoogle Scholar
• Lim WK, Soh ZD, Choi HKY et al. Epithelium-on photorefractive intrastromal cross-linking (PiXL) for reduction of low myopia. Clin Ophthalmol 2017; 11: 1205–1211. doi:10.2147/OPTH.S137712.
   PubMed Web of Science ®Google Scholar
• Elling M, Kersten-Gomez I, Dick HB. Photorefractive intrastromal corneal crosslinking for treatment of myopic refractive error: findings from 12-month prospective study using an epithelium-off protocol. J Cataract Refract Surg 2018 Apr; 44: 487–495. doi:10.1016/j.jcrs.2018.01.022.
   PubMed Web of Science ®Google Scholar
• Fredriksson A, Näslund S, Behndig A. A prospective evaluation of photorefractive intrastromal cross-linking for the treatment of low-grade myopia. Acta Ophthalmol 2020 Mar; 98: 201–206. doi:10.1111/aos.14190.
   PubMed Web of Science ®Google Scholar
• El Hout S, Cassagne M, Sales de Gauzy T et al. Transepithelial photorefractive intrastromal corneal crosslinking versus photorefractive keratectomy in low myopia. J Cataract Refract Surg 04 2019; 45: 427–436. doi:10.1016/j.jcrs.2018.11.008.
   PubMed Web of Science ®Google Scholar
• Näslund S, Fredriksson A, Alm A et al. Treatment effect with 2 photorefractive intrastromal cross-linking protocols in low-grade myopia through 24-month follow-up. Acta Ophthalmol 2021 Aug; 99: 519–526. doi:10.1111/aos.14669.
   PubMed Web of Science ®Google Scholar
• Kanellopoulos J, Asimellis G. Hyperopic correction: clinical validation with epithelium-on and epithelium-off protocols, using variable fluence and topographically customized collagen corneal crosslinking. Clin Ophthalmol 2014 Dec 1; 2425. doi:10.2147/opth.s68222.
   PubMedGoogle Scholar
• Stodulka P, Halasova Z, Slovak M et al. Photorefractive intrastromal crosslinking for correction of hyperopia: 12-month results. J Cataract Refract Surg 03 2020; 46: 434–440. doi:10.1097/j.jcrs.0000000000000074.
   PubMed Web of Science ®Google Scholar
• Seiler TG, Fischinger I, Koller T et al. Customized corneal cross-linking: one-year results. Am J Ophthalmol 2016 Jun 01; 166: 14–21. doi:10.1016/j.ajo.2016.02.029.
   PubMed Web of Science ®Google Scholar
• Cassagne M, Pierné K, Galiacy SD et al. Customized topography-guided corneal collagen cross-linking for keratoconus. J Refract Surg 2017; 33: 290–297. doi:10.3928/1081597X-20170201-02.
   PubMed Web of Science ®Google Scholar
• Mazzotta C, Sgheri A, Bagaglia SA et al. Customized corneal crosslinking for treatment of progressive keratoconus: clinical and OCT outcomes using a transepithelial approach with supplemental oxygen. J Cataract Refract Surg 2020; 46: 1582–1587. doi:10.1097/j.jcrs.0000000000000347.
   PubMed Web of Science ®Google Scholar
• Nishida T, Kojima T, Kataoka T et al. Comparison of corneal biomechanical properties and corneal tomography between customized and accelerated corneal crosslinking in eyes with keratoconus. Cornea 2021; 40: 851–858. doi:10.1097/ICO.0000000000002572.
   PubMed Web of Science ®Google Scholar
• Salman A, Ali A, Rafea S et al. Long-term visual, anterior and posterior corneal changes after crosslinking for progressive keratoconus. Eur J Ophthalmol 2021 Oct 30; 2021: 112067212110528. doi:10.1177/11206721211052878.
   Google Scholar
• Nti AN, Berntsen DA. Optical changes and visual performance with orthokeratology. Clin Exp Optom 2020 Jan; 103: 44–54. doi:10.1111/cxo.12947.
   PubMed Web of Science ®Google Scholar
• Wu J, Fang W, Xu H et al. The biomechanical response of the cornea in orthokeratology. Front Bioeng Biotechnol 2021; 9: 743745. doi:10.3389/fbioe.2021.743745.
   PubMed Web of Science ®Google Scholar
• Liao C, Lin X, Keel S et al. Effects of corneal crosslinking on corneal shape stabilization after orthokeratology. Sci Rep 2020 Feb 11; 10: 2357. doi:10.1038/s41598-020-59157-2.
   PubMed Web of Science ®Google Scholar
• Kim WK, Kim BJ, Ryu IH et al. Corneal epithelial and stromal thickness changes in myopic orthokeratology and their relationship with refractive change. PLoS One 2018; 13: e0203652. doi:10.1371/journal.pone.0203652.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Yanai R, Fau - Chikamoto N et al. Reversibility of effects of orthokeratology on visual acuity, refractive error, corneal topography, and contrast sensitivity. Eye contact lens 2008; 34: 1542–233X. Electronic.
   Web of Science ®Google Scholar
• Dolgin E. The myopia boom. Nature 2015 Mar 01 2015; 519: 276–278. doi:10.1038/519276a.
   PubMed Web of Science ®Google Scholar
• Rada JA, Shelton S, Norton TT. The sclera and myopia. Exp Eye Res 2006 Feb; 82: 185–200. doi:10.1016/j.exer.2005.08.009.
   PubMed Web of Science ®Google Scholar
• Harper AR, Summers JA. The dynamic sclera: extracellular matrix remodeling in normal ocular growth and myopia development. Exp Eye Res 2015; 133. 100–111. doi:10.1016/j.exer.2014.07.015.
   PubMed Web of Science ®Google Scholar
• Wollensak G, Spoerl E. Collagen crosslinking of human and porcine sclera. J Cataract Refract Surg 2004 Mar; 30: 689–695. doi:10.1016/j.jcrs.2003.11.032.
   PubMed Web of Science ®Google Scholar
• Wollensak G, Iomdina E, Dittert D-D et al. Cross-linking of scleral collagen in the rabbit using riboflavin and UVA. Acta Ophthalmol Scand 2005 Aug 01; 83: 477–482. doi:10.1111/j.1600-0420.2005.00447.x.
   PubMedGoogle Scholar
• Iseli HP, Spoerl E, Wiedemann P et al. Efficacy and safety of blue-light scleral cross-linking. J Refract Surg 2008 Sep; 24: S752–5. doi:10.3928/1081597x-20080901-21.
   PubMed Web of Science ®Google Scholar
• Wollensak G, Iomdina E. Long-term biomechanical properties of rabbit sclera after collagen crosslinking using riboflavin and ultraviolet a (UVA). Acta Ophthalmol 2009 Mar; 87: 193–198. doi:10.1111/j.1755-3768.2008.01229.x.
   PubMed Web of Science ®Google Scholar
• Wang M, Zhang F, Qian X et al. Regional Biomechanical properties of human sclera after cross-linking by riboflavin/ultraviolet a. J Refract Surg 2012 Oct; 28: 723–728. doi:10.3928/1081597x-20120921-08.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li Z, Liu L et al. Comparison of Riboflavin/Ultraviolet-A cross-linking in porcine, rabbit, and human sclera. Biomed Res Int 2014 Jan 02; 2014: 194204. doi:10.1155/2014/194204.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zou Y, Zhang F et al. Efficacy of blue-light cross-linking on human scleral reinforcement. Optom Vis Sci 2015 Aug; 92: 873–878. doi:10.1097/opx.0000000000000642.
   PubMed Web of Science ®Google Scholar
• Gawargious BA, Le A, Lesgart M et al. Differential regional stiffening of sclera by collagen cross-linking. Curr Eye Res 2020 Jun; 45: 718–725. doi:10.1080/02713683.2019.1694157.
   PubMed Web of Science ®Google Scholar
• Liu TX, Wang Z. Collagen crosslinking of porcine sclera using genipin. Acta Ophthalmol 2013 Jun; 91: e253–7. doi:10.1111/aos.12172.
   PubMed Web of Science ®Google Scholar
• Wang M, Corpuz CCC. Effects of scleral cross-linking using genipin on the process of form-deprivation myopia in the guinea pig: a randomized controlled experimental study. BMC Ophthalmol 2015 Jun 29; 15: 89. doi:10.1186/s12886-015-0086-z.
   PubMed Web of Science ®Google Scholar
• Dotan A, Kremer I, Gal-Or O et al. Scleral cross-linking using riboflavin and ultraviolet-A radiation for prevention of axial myopia in a rabbit model. J Vis Exp 2016; e53201. doi:10.3791/53201.
   PubMed Web of Science ®Google Scholar
• Liu S, Li S, Wang B et al. Scleral cross-linking using riboflavin UVA irradiation for the prevention of myopia progression in a guinea pig model: blocked axial extension and altered scleral microstructure. PLoS One 2016; 11: e0165792. doi:10.1371/journal.pone.0165792.
   PubMed Web of Science ®Google Scholar
• Levy AM, Fazio MA, Grytz R. Experimental myopia increases and scleral crosslinking using genipin inhibits cyclic softening in the tree shrew sclera. Ophthalmic Physiol Opt 2018 May; 38: 246–256. doi:10.1111/opo.12454.
   PubMed Web of Science ®Google Scholar
• Li X, Wu M, Zhang L et al. Riboflavin and ultraviolet a irradiation for the prevention of progressive myopia in a guinea pig model. Exp Eye Res 2017 Dec; 165: 1–6. doi:10.1016/j.exer.2017.08.019.
   PubMed Web of Science ®Google Scholar
• Lin X, Naidu RK, Dai J et al. Scleral cross-linking using glyceraldehyde for the prevention of axial elongation in the rabbit: blocked axial elongation and altered scleral microstructure. Curr Eye Res 2019 Feb; 44: 162–171. doi:10.1080/02713683.2018.1522647.
   PubMed Web of Science ®Google Scholar
• Spoerl E, Boehm AG, Pillunat LE. The influence of various substances on the biomechanical behavior of lamina cribrosa and peripapillary sclera. Invest Ophthalmol Vis Sci 2005 Apr; 46: 1286–1290. doi:10.1167/iovs.04-0978.
   PubMed Web of Science ®Google Scholar
• Kimball EC, Nguyen C, Steinhart MR et al. Experimental scleral cross-linking increases glaucoma damage in a mouse model. Exp Eye Res 2014; 128: 129–140. doi:10.1016/j.exer.2014.08.016.
   PubMed Web of Science ®Google Scholar
• Wang M, Zhang F, Liu K et al. Safety evaluation of rabbit eyes on scleral collagen cross-linking by riboflavin and ultraviolet a. Clin Experiment Ophthalmol 2015 Mar; 43: 156–163. doi:10.1111/ceo.12392.
   PubMed Web of Science ®Google Scholar
• Sun M, Zhang F, Ouyang B et al. Study of retina and choroid biological parameters of rhesus monkeys eyes on scleral collagen cross-linking by riboflavin and ultraviolet a. PLoS One 2018; 13: e0192718. doi:10.1371/journal.pone.0192718.
   PubMed Web of Science ®Google Scholar
• Ou-Yang BW, Sun MS, Wang MM et al. Early changes of ocular biological parameters in rhesus monkeys after scleral cross-linking with Riboflavin/Ultraviolet-A. J Refract Surg 2019 May 1 2019; 35: 333–339. doi:10.3928/1081597x-20190410-03.
   PubMed Web of Science ®Google Scholar
• Li Y, Liu C, Sun M et al. Ocular safety evaluation of blue light scleral cross-linking in vivo in rhesus macaques. Graefes Arch Clin Exp Ophthalmol 2019 Jul; 257: 1435–1442. doi:10.1007/s00417-019-04346-7.
   PubMed Web of Science ®Google Scholar
• Zhang F, Lai L. Advanced research in scleral cross-linking to prevent from progressive myopia. Asia-Pac J Ophthalmol 2021; 10: 161–166. doi:10.1097/APO.0000000000000340.
   PubMed Web of Science ®Google Scholar
• Cho M, Kanellopoulos AJ. Safety and efficacy of prophylactic ultraviolet-a-induced crosslinking after high-risk myopic photorefractive keratectomy. Investig Ophthalmol Vis Sci 2009; 50: 5470.
   Google Scholar
• Randleman JB, Woodward M, Lynn MJ et al. Risk assessment for ectasia after corneal refractive surgery. Ophthalmology 2008 Jan; 115: 37–50. doi:10.1016/j.ophtha.2007.03.073.
   PubMed Web of Science ®Google Scholar
• Kanellopoulos AJ. Long-term safety and efficacy follow-up of prophylactic higher fluence collagen cross-linking in high myopic laser-assisted in situ keratomileusis. Clin Ophthalmol 2012; 6: 1125–1130. doi:10.2147/opth.S31256.
   PubMedGoogle Scholar
• Ganesh S, Brar S. Clinical outcomes of small incision lenticule extraction with accelerated cross-linking (ReLex SMILE Xtra) in patients with thin corneas and borderline topography. J Ophthalmol 2015 Jun 28; 2015: 263412. doi:10.1155/2015/263412.
   PubMed Web of Science ®Google Scholar
• Lee H, Yong Kang DS, Ha BJ et al. Comparison of outcomes between combined transepithelial photorefractive keratectomy with and without accelerated corneal collagen cross-linking: a 1-year study. Cornea 2017 Oct; 36: 1213–1220. doi:10.1097/ico.0000000000001308.
   PubMed Web of Science ®Google Scholar
• Konstantopoulos A, Liu Y-C, Teo EP et al. Cornealstability of LASIK and SMILE when combined with collagen cross-linking. Transl Vis Sci Technol 2019; 8: 21. doi:10.1167/tvst.8.3.21.
   PubMed Web of Science ®Google Scholar
• Kanellopoulos AJ. Long-term safety and efficacy follow-up of prophylactic higher fluence collagen cross-linking in high myopic laser-assisted in situ keratomileusis. Clin Ophthalmol (Auckland, NZ) 2012; 6. 1125. doi:10.2147/OPTH.S31256.
   PubMedGoogle Scholar
• Celik HU, Alagöz N, Yildirim Y et al. Accelerated corneal crosslinking concurrent with laser in situ keratomileusis. J Cataract Refract Surg 2012; 38: 1424–1431. doi:10.1016/j.jcrs.2012.03.034.
   PubMed Web of Science ®Google Scholar
• Tomita M, Yoshida Y, Yamamoto Y et al. In vivo confocal laser microscopy of morphologic changes after simultaneous LASIK and accelerated collagen crosslinking for myopia: one-year results. J Cataract Refract Surg 2014; 40: 981–990. doi:10.1016/j.jcrs.2013.10.044.
   PubMed Web of Science ®Google Scholar
• Kanellopoulos AJ, Asimellis G. Combined laser in situ keratomileusis and prophylactic high-fluence corneal collagen crosslinking for high myopia: two-year safety and efficacy. J Cataract Refract Surg 2015; 41: 1426–1433. doi:10.1016/j.jcrs.2014.10.045.
   PubMed Web of Science ®Google Scholar
• Seiler TG, Fischinger I, Koller T et al. Superficial corneal crosslinking during laser in situ keratomileusis. J Cataract Refract Surg 2015; 41: 2165–2170. doi:10.1016/j.jcrs.2015.03.020.
   PubMed Web of Science ®Google Scholar
• Wu Y, Tian L, Wang L-Q et al. Efficacy and safety of LASIK combined with accelerated corneal collagen cross-linking for myopia: six-month study. Biomed Res Int 2016; 2016: doi:10.1155/2016/5083069.
   Web of Science ®Google Scholar
• Low JR, Lim L, Koh JCW et al. Suppl-1, M3: simultaneous accelerated corneal crosslinking and laser in situ keratomileusis for the treatment of high myopia in asian eyes. Open Ophthalmol J 2018; 12. 143. doi:10.2174/1874364101812010143.
   PubMed Web of Science ®Google Scholar
• Xu W, Tao Y, Wang L et al. Evaluation of biomechanical changes in myopia patients with unsatisfactory corneas after femto second-laser in situ keratomileusis (fs-lasik) concurrent with accelerated corneal collagen cross-linking using corvis-st: two-year follow-up results. Med Sci Monit 2017; 23: 3649. doi:10.12659/MSM.905493.
   PubMed Web of Science ®Google Scholar
• Taneri S, Kiessler S, Rost A et al. Corneal ectasia after LASIK combined with prophylactic corneal cross-linking. J Refract Surg 2017; 33: 50–52. doi:10.3928/1081597X-20161019-03.
   PubMed Web of Science ®Google Scholar
• Aslanides IM, Mukherjee AN. Adjuvant corneal crosslinking to prevent hyperopic LASIK regression. Clin Ophthalmol (Auckland, NZ) 2013; 7. 637: doi:10.2147/OPTH.S39796.
   PubMedGoogle Scholar
• Kanellopoulos AJ, Kahn J. Topography-guided hyperopic LASIK with and without high irradiance collagen cross-linking: initial comparative clinical findings in a contralateral eye study of 34 consecutive patients. J Refract Surg 2012; 28: S837–840. doi:10.3928/1081597X-20121005-05.
   PubMed Web of Science ®Google Scholar
• Lee H, Kang DSY, Ha BJ et al. Comparison of outcomes between combined transepithelial photorefractive keratectomy with and without accelerated corneal collagen cross-linking: a 1-year study. Cornea 2017; 36: 1213–1220. doi:10.1097/ICO.0000000000001308.
   PubMed Web of Science ®Google Scholar
• Sachdev GS, Ramamurthy S, Dandapani R. Comparative analysis of safety and efficacy of photorefractive keratectomy versus photorefractive keratectomy combined with crosslinking. Clin Ophthalmol (Auckland, NZ) 2018; 12: 783. doi:10.2147/OPTH.S156500.
   PubMed Web of Science ®Google Scholar
• Ohana O, Kaiserman I, Domniz Y et al. Outcomes of simultaneous photorefractive keratectomy and collagen crosslinking. Can J Ophthalmol 2018 Oct; 53: 523–528. doi:10.1016/j.jcjo.2017.12.003.
   PubMed Web of Science ®Google Scholar
• Ng AL, Chan TC, Cheng GP et al. Comparison of the early clinical outcomes between combined small-incision lenticule extraction and collagen cross-linking versus SMILE for myopia. J Ophthalmol 2016; 2016: 1–7. doi:10.1155/2016/2672980.
   Web of Science ®Google Scholar
• Osman IM, Helaly HA, Abou Shousha M et al. Corneal safety and stability in cases of small incision lenticule extraction with collagen cross-linking (SMILE Xtra). J Ophthalmol 2019; 2019. 1–10. doi:10.1155/2019/6808062.
   Web of Science ®Google Scholar
• Liu C, Wang Z, Wu D et al. Comparison of 1-year outcomes between small incision lenticule extraction with prophylactic cross-linking and femtosecond laser-assisted in situ keratomileusis with prophylactic cross-linking. Cornea 2021 Jan; 40: 12–18. doi:10.1097/ico.0000000000002547.
   PubMed Web of Science ®Google Scholar
• Siu GD, Young AL, Jhanji V. Alternatives to corneal transplantation for the management of bullous keratopathy. 2014; 25: 347–352. doi:10.1097/ICU.0000000000000062.
   Google Scholar
• Luchs JI, Cohen EJ, Rapuano CJ et al. Ulcerative keratitis in bullous keratopathy. 1997; 104: 816–822. doi:10.1016/S0161-6420(97)30228-0.
   Google Scholar
• Lin P-Y, Wu C-C, Lee S-M. Combined phototherapeutic keratectomy and therapeutic contact lens for recurrent erosions in bullous keratopathy. Br J Ophthalmol 2001; 85: 908–911. doi:10.1136/bjo.85.8.908.
   PubMed Web of Science ®Google Scholar
• Liu T, Xu Y, Sun D et al. Histological evaluation of corneal scar formation in pseudophakic bullous keratopathy. PLoS One 2012; 7: e39201. doi:10.1371/journal.pone.0039201.
   PubMed Web of Science ®Google Scholar
• Wollensak G, Aurich H, Wirbelauer C et al. Potential use of riboflavin/UVA cross-linking in bullous keratopathy. Ophthalmic Res 2009; 41: 114–117. doi:10.1159/000187630.
   PubMed Web of Science ®Google Scholar
• Choy BNK, Ng ALK, Zhu MM et al. Randomized control trial on the effectiveness of collagen cross-linking on bullous keratopathy. Cornea 2020; 39: 1341–1347. doi:10.1097/ICO.0000000000002395.
   PubMed Web of Science ®Google Scholar
• Kasai K, Kato N, Den S et al. A prospective, randomized clinical study comparing accelerated corneal collagen crosslinking with 5% NaCl hypertonic saline for bullous keratopathy in Asian eyes. Medicine 2019; 98: e18256. doi:10.1097/MD.0000000000018256.
   PubMed Web of Science ®Google Scholar
• Arora R, Manudhane A, Saran RK et al. Role of corneal collagen cross-linking in pseudophakic bullous keratopathy: a clinicopathological study. Ophthalmology 2013; 120: 2413–2418. doi:10.1016/j.ophtha.2013.07.038.
   PubMed Web of Science ®Google Scholar
• Sharma N, Roy S, Maharana PK et al. Outcomes of corneal collagen crosslinking in pseudophakic bullous keratopathy. Cornea 2014; 33: 243–246. doi:10.1097/ICO.0000000000000004.
   PubMed Web of Science ®Google Scholar
• Ghanem RC, Santhiago MR, Berti TB et al. Collagen crosslinking with riboflavin and ultraviolet-A in eyes with pseudophakic bullous keratopathy. J Cataract Refract Surg 2010; 36: 273–276. doi:10.1016/j.jcrs.2009.07.041.
   PubMed Web of Science ®Google Scholar
• Khan MS, Basit I, Ishaq M et al. Corneal collagen cross linking (CXL) in treatment of pseudophakic bullous keratopathy. Pak J Med Sci 2016; 32: 965. doi:10.12669/pjms.324.10138.
   PubMed Web of Science ®Google Scholar
• Wahab AMA, Mahmoud DA, Elsayed M et al. Trans epithelial collagen crosslinking in pseudophakic bullous keratopathy. Tanta Med Sci J 2014 July; 9: 46–53.
   Google Scholar
• Kozobolis V, Labiris G, Gkika M et al. UV-A collagen cross-linking treatment of bullous keratopathy combined with corneal ulcer. Cornea 2010; 29: 235–238. doi:10.1097/ICO.0b013e3181a81802.
   PubMed Web of Science ®Google Scholar
• Ucakhan OO, Saglik A. Outcome of two corneal collagen crosslinking methods in bullous keratopathy due to Fuchs’ endothelial dystrophy. Case Rep Med 2014; 2014: 1–5. doi:10.1155/2014/463905.
   Google Scholar
• Ono T, Mori Y, Nejima R et al. Sustainability of pain relief after corneal collagen cross-linking in eyes with bullous keratopathy. Asia-Pac J Ophthalmol (Philadelphia, Pa) 2018; 7: 291–295. doi:10.22608/APO.201832.
   PubMed Web of Science ®Google Scholar
• Gadelha DNB, Cavalcanti BM, Bravo Filho V et al. Efeito terapêutico do ”cross-linking” corneano na ceratopatia bolhosa sintomática. Arq Bras Oftalmol 2009; 72: 462–466. doi:10.1590/S0004-27492009000400007.
   PubMedGoogle Scholar
• Arriola-Villalobos P, Benito-Pascual B, Ariño-Gutiérrez M et al. Poor re-epithelialization following corneal collagen crosslinking with riboflavin-uva for advanced bullous keratopathy. Case series 2021; 44: 531–536. doi:10.1016/j.jfo.2020.07.021.
   Google Scholar
• de Toledo JA, de la Paz MF, Barraquer RI et al. Long-term progression of astigmatism after penetrating keratoplasty for keratoconus: evidence of late recurrence. Cornea 2003 May; 22: 317–323. doi:10.1097/00003226-200305000-00008.
   PubMed Web of Science ®Google Scholar
• Bourges JL, Savoldelli M, Dighiero P et al. Recurrence of keratoconus characteristics: a clinical and histologic follow-up analysis of donor grafts. Ophthalmology 2003 Oct; 110: 1920–1925. doi:10.1016/s0161-6420(03)00617-1.
   PubMed Web of Science ®Google Scholar
• Szczotka-Flynn L, McMahon TT, Lass JH et al. Late-stage progressive corneal astigmatism after penetrating keratoplasty for keratoconus. Eye Contact Lens 2004 Apr; 30: 105–110. doi:10.1097/01.icl.00000118526.35929.0f.
   PubMedGoogle Scholar
• Mukherjee A, Hayes S, Aslanides I et al. Donor cross-linking for keratoplasty: a laboratory evaluation. Graefes Arch Clin Exp Ophthalmol 2015 Dec; 253: 2223–2228. doi:10.1007/s00417-015-3160-6.
   PubMed Web of Science ®Google Scholar
• Ziaei M, Gokul A, Vellara H et al. Peripheral cornea crosslinking before deep anterior lamellar keratoplasty. Med Hypothesis Discov Innov Ophthalmol Summer 2020; 9: 127–134.
   PubMedGoogle Scholar
• Huang T, Ye R, Ouyang C et al. Use of donors predisposed by corneal collagen cross-linking in penetrating keratoplasty for treating patients with keratoconus. Am J Ophthalmol 2017 Dec; 184: 115–120. doi:10.1016/j.ajo.2017.10.003.
   PubMed Web of Science ®Google Scholar